JCI vs MDXG · P/E 44, rev $23.60B vs P/E 18, rev $123.4M
Johnson Controls International PLC (JCI) versus MiMedx Group Inc (MDXG) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported MDXG revenue for 2026-06-30 was $123.4M. Net income was -$25.7M. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.
Not investment advice. Open the JCI and MDXG stock pages for the full models.
Not investment advice.